LUYE Pharma Group was established in 1994 in China and lists in Hong Kong Exchanges.
We focus on developing, producing, marketing and selling innovative pharmaceutical
products in three of the largest and fastest growing therapeutic areas in the PRC—oncology, cardiovascular system, and alimentary tract and metabolism. Besides, CNS is expected to become another key area of focus.
more >
Year of Establishment:
1994
Total Number of Staff:
more than 500
Main Competitive Advantages:
Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Annual Turnover(USD):
250,000,000 to 499,999,999
Main Sales Markets:
Eastern Europe,Asia
Advantage Description: